Searchable abstracts of presentations at key conferences in endocrinology

ea0086p366 | Thyroid | SFEBES2022

Use of Burch-Wartofsky score when assessing the severity of hyperthyroidism, a retrospective study

Vennard Hannah , Duvieusart Ysaline , McNeilly Jane , Kernohan Andrew

Introduction: Thyroid storm, a life-threatening endocrine emergency, requires prompt intervention and treatment to improve outcomes. The diagnosis is made clinically, based on symptoms including hyperpyrexia, tachycardia, nausea, diarrhoea and altered cognition. The Burch-Wartofsky (BW) score is a symptom-based score recommended to determine the likelihood of thyroid storm. This retrospective study aims to determine use of the BW scale and its effect on management.<p class...

ea0065p146 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Frequency of pathogenic germline variants in hereditary endocrine tumour genes in patients with discordant cancer phenotypes

Vennard Hannah , Maniam Pavithran , Berg Jonathan , Goudie David , Newey Paul

Background: Advances in next-generation sequencing facilitate the simultaneous evaluation of large numbers of cancer predisposition genes (CPGs) in patients with cancer irrespective of family history or tumour phenotype. Several studies have reported the frequent occurrence of germline mutations in CPGs in patients with discordant cancer types raising the possibility of novel gene-cancer associations. The current study aimed to evaluate the significance of germline mutations i...

ea0065p132 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Risk stratification of variants of unknown significance (VUS) in monogenic endocrine tumour genes using population-level genetic data and computational analysis

Vennard Hannah , Maroteau Cyrielle , Berg Jonathan , Goudie David , Palmer Colin , Newey Paul

Background: Identifying individuals harbouring germline mutations in hereditary cancer genes provides opportunities for tumour surveillance programs, disease-specific treatment and cascade testing in family members but is reliant on accurate variant interpretation, which may be confounded by imprecise methods for ascribing pathogenicity. Where insufficient evidence supports a definitive classification, ‘variant of uncertain significance’ (VUS) status is applied, whic...